Price Position and Structural State
Bio Protocol (BIO) closed at 0.02743 USDT on August 29, 2026, down 1.65%. The asset now sits in a sideways structure inside its 55-day range. Current 55-day support is near 0.02164 USDT, with resistance near 0.03481 USDT. Price is near the middle of the range, so the market has no clear structural edge until it closes outside these levels.
Moving Averages and Trend Context
BIO is trading below short-term moving averages while still holding above longer-term support. MA200 at 0.028111 USDT may cap short-term recovery attempts, while MA20 at 0.027281 USDT remains the more significant structural support area. The structure resembles a pullback within a broader trend more than a full trend failure.
Trading Friction and Price Efficiency
BIO shows moderate trading friction, with a 3-day friction score of 46.1. The score combines price progress, wick rejection, and volume confirmation. Recent candles show mixed acceptance, so price is moving but still showing some noise. Moves near support or resistance need a cleaner daily close before they carry stronger weight.
Open Interest, Funding, and Positioning
Open interest fell -5.16% in one day and remains near the lower side of its 180-day range. This shows participation is weak and exposure is still being reduced.
Funding is positive on the 24-hour average at +0.005000%, with the 7-day average also positive at +0.005000%. This shows sustained long-side cost pressure across both short and medium windows.
The long/short ratio is 0.94, showing near balance between long and short accounts. It sits near the middle of its 60-day range, so account-side positioning looks balanced.
Correlation, Beta, and Index Relationship
BIO shows a moderate relationship with the broader crypto market (Sigloid Index). Correlation indicates partial co-movement with the index, while R² suggests that index behavior explains only part of its movement. This means broader market direction has some influence, but asset-specific factors remain important. Over the 30-day window, the relationship is stable. Over the 60-day window, the relationship is strengthening. Over the 180-day window, the relationship is stable.
| Window | Correlation | Beta | R² | Read |
|---|---|---|---|---|
| 30D | 0.571 | 0.975 | 0.327 | Moderate linkage |
| 60D | 0.563 | 0.933 | 0.317 | Moderate linkage |
| 180D | 0.276 | 0.833 | 0.076 | Weak linkage |
Momentum, Volatility, and Indicator Pressure
BIO is showing wider movement, but participation is not fully backing it. ATR% reads 8.85, close to the bottom of its full historical range, while Bollinger Band width% reads 37.38, near the lower side of its full historical range. 20-day Volume Z-score is -0.72, showing slightly below-normal participation.
ROC14 is +11.64%, while RSI is 50.60 and MACD histogram remains negative. Multi-day acceleration has improved, but the broader momentum picture is still incomplete.
The read is still incomplete: momentum is improving, but volatility or participation has not confirmed the move strongly enough.
Broader Market Regime
The Sigloid Index remains in a bullish regime, showing broad strength across the market. BIO has a moderate link to that market condition, so market strength can still influence price behavior, while asset specific factors also matter.
Key Levels for the Next State Change
For BIO, the next structural shift depends on range boundaries. A daily close above 55-day resistance at 0.03481 USDT establishes a bullish regime, while a daily close below 55-day support at 0.02164 USDT confirms a bearish regime.